26
|
Bessis D, Cavé H, Verloes A, Lacombe D. Manifestations dermatologiques du syndrome de Costello : étude prospective et multicentrique française de 20 patients. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Bergeret B, Lipsker D, Pallure V, Barete S, Gottlieb J, Durand L, Pers YM, Bessis D. Kératodermie palmo-plantaire livedoïde, une manifestation cutanée méconnue du lupus érythémateux systémique ou subaigu. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Luu M, Vabres P, Devilliers H, Loffroy R, Carpentier M, Maurer A, Yousfi M, Fleck C, Phan A, Martin L, Morice-Picard F, Petit F, Willems M, Bessis D, Jacquemont ML, Maruani A, Chiaverini C, Bardou M, Faivre L. Enseignements de l’essai TOTEM évaluant le tasélisib, inhibiteur de la PI3 K, dans les syndromes hypertrophiques liés à PIK3CA. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
29
|
Bessis D, Verloes A, Cavé H, Geneviève D. Manifestations dermatologiques du syndrome cardio-facio-cutané: étude prospective et multicentrique française de 45 patients. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
30
|
Bessis D, Rigau V, Marque M, Best M, Bigorre M, Blanchet C, Akkari M, Captier G. Fibrolipome lingual congénital. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
31
|
Mazaud C, Staumont D, Beauchet A, Catteau B, Lasek A, Puzenat E, Aubin F, Barbarot S, Aubert H, Mallet S, Seneschal J, Bessis D, Tauber M, Delaunay J, Droitcourt C, Abasq C, Jachiet M, Nosbaum A, Mahé E. Dupilumab dans la dermatite atopique modérée à sévère de l’enfant. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
32
|
Poujade L, Tran T, Marque M, Sarrabay G, Bessis D. Syndrome auto-inflammatoire avec dermatose neutrophilique associé à des mutations de l’exon 2 de la pyrine. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
33
|
Bertrand AS, Dereure O, Girard C, Bessis D, Guillot B. Place du rituximab dans le traitement de la pemphigoïde des muqueuses. Ann Dermatol Venereol 2019; 146:659-661. [DOI: 10.1016/j.annder.2019.07.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2017] [Revised: 03/01/2019] [Accepted: 07/05/2019] [Indexed: 11/27/2022]
|
34
|
Bessis D, Miquel J, Bourrat E, Chiaverini C, Morice‐Picard F, Abadie C, Manna F, Baumann C, Best M, Blanchet P, Bursztejn A, Capri Y, Coubes C, Giuliano F, Guillaumont S, Hadj‐Rabia S, Jacquemont M, Jeandel C, Lacombe D, Mallet S, Mazereeuw‐Hautier J, Molinari N, Pallure V, Pernet C, Philip N, Pinson L, Sarda P, Sigaudy S, Vial Y, Willems M, Genevievé D, Verloes A, Cavé H. 努南综合征的皮肤病表现. Br J Dermatol 2019. [DOI: 10.1111/bjd.17978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Bessis D, Miquel J, Bourrat E, Chiaverini C, Morice‐Picard F, Abadie C, Manna F, Baumann C, Best M, Blanchet P, Bursztejn A, Capri Y, Coubes C, Giuliano F, Guillaumont S, Hadj‐Rabia S, Jacquemont M, Jeandel C, Lacombe D, Mallet S, Mazereeuw‐Hautier J, Molinari N, Pallure V, Pernet C, Philip N, Pinson L, Sarda P, Sigaudy S, Vial Y, Willems M, Genevievé D, Verloes A, Cavé H. Dermatological manifestations in Noonan syndrome. Br J Dermatol 2019. [DOI: 10.1111/bjd.17961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
36
|
Castela E, Tulic M, Rozières A, Bourrat E, Nicolas J, Kanitakis J, Vabres P, Bessis D, Mazereeuw J, Morice‐Picard F, Baty D, Berard F, Lacour J, Passeron T, Chiaverini C. 泛发重度 EBS 是一种炎症性疾病. Br J Dermatol 2019. [DOI: 10.1111/bjd.17488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Castela E, Tulic M, Rozières A, Bourrat E, Nicolas J, Kanitakis J, Vabres P, Bessis D, Mazereeuw J, Morice‐Picard F, Baty D, Berard F, Lacour J, Passeron T, Chiaverini C. EBS generalized severe is an inflammatory disease. Br J Dermatol 2019. [DOI: 10.1111/bjd.17475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Bessis D, Miquel J, Bourrat E, Chiaverini C, Morice-Picard F, Abadie C, Manna F, Baumann C, Best M, Blanchet P, Bursztejn AC, Capri Y, Coubes C, Giuliano F, Guillaumont S, Hadj-Rabia S, Jacquemont ML, Jeandel C, Lacombe D, Mallet S, Mazereeuw-Hautier J, Molinari N, Pallure V, Pernet C, Philip N, Pinson L, Sarda P, Sigaudy S, Vial Y, Willems M, Geneviève D, Verloes A, Cavé H. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation. Br J Dermatol 2019; 180:1438-1448. [PMID: 30417923 DOI: 10.1111/bjd.17404] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2018] [Indexed: 01/08/2023]
Abstract
BACKGROUND Data on dermatological manifestations of Noonan syndrome (NS) remain heterogeneous and are based on limited dermatological expertise. OBJECTIVES To describe the dermatological manifestations of NS, compare them with the literature findings, and test for dermatological phenotype-genotype correlations with or without the presence of PTPN11 mutations. METHODS We performed a large 4-year, prospective, multicentric, collaborative dermatological and genetic study. RESULTS Overall, 129 patients with NS were enrolled, including 65 patients with PTPN11-NS, 34 patients with PTPN11-NS with multiple lentigines (NSML), and 30 patients with NS who had a mutation other than PTPN11. Easy bruising was the most frequent dermatological finding in PTPN11-NS, present in 53·8% of patients. Multiple lentigines and café-au-lait macules (n ≥ 3) were present in 94% and 80% of cases of NSML linked to specific mutations of PTPN11, respectively. Atypical forms of NSML could be associated with NS with RAF1 or NRAS mutations. In univariate analysis, patients without a PTPN11 mutation showed (i) a significantly higher frequency of keratinization disorders (P = 0·001), including keratosis pilaris (P = 0·005), ulerythema ophryogenes (P = 0·0001) and palmar and/or plantar hyperkeratosis (P = 0·06, trend association), and (ii) a significantly higher frequency of scarce scalp hair (P = 0·035) and scarce or absent eyelashes (P = 0·06, trend association) than those with PTPN11 mutations. CONCLUSIONS The cutaneous phenotype of NS with a PTPN11 mutation is generally mild and nonspecific, whereas the absence of a PTPN11 mutation is associated with a high frequency of keratinization disorders and hair abnormalities.
Collapse
|
39
|
Bessis D, Petit A, Battistella M, Bourrat E, Girard C, Pallure V, Marque M, Lacour J, Vitetta A, Bieth É, Selves J, Solassol J, Vendrell J. Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic
FGFR3
and
FGFR2
mutations. Br J Dermatol 2019; 180:955-957. [DOI: 10.1111/bjd.17581] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
40
|
Bessis D, Morice‐Picard F, Bourrat E, Abadie C, Aouinti S, Baumann C, Best M, Bursztejn A, Capri Y, Chiaverini C, Coubes C, Giuliano F, Hadj‐Rabia S, Jacquemont M, Lacombe D, Lyonnet S, Mallet S, Mazereeuw‐Hautier J, Miquel J, Molinari N, Parfait B, Pernet C, Philip N, Pinson L, Pouvreau N, Vial Y, Sarda P, Sigaudy S, Verloes A, Cavé H, Geneviéve D. 心脸皮肤综合症中的皮肤表现. Br J Dermatol 2019. [DOI: 10.1111/bjd.17385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
41
|
Bessis D, Morice‐Picard F, Bourrat E, Abadie C, Aouinti S, Baumann C, Best M, Bursztejn A, Capri Y, Chiaverini C, Coubes C, Giuliano F, Hadj‐Rabia S, Jacquemont M, Lacombe D, Lyonnet S, Mallet S, Mazereeuw‐Hautier J, Miquel J, Molinari N, Parfait B, Pernet C, Philip N, Pinson L, Pouvreau N, Vial Y, Sarda P, Sigaudy S, Verloes A, Cavé H, Geneviéve D. Dermatological manifestations in cardiofaciocutaneous syndrome. Br J Dermatol 2019. [DOI: 10.1111/bjd.17371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
42
|
Castela E, Tulic MK, Rozières A, Bourrat E, Nicolas JF, Kanitakis J, Vabres P, Bessis D, Mazereeuw J, Morice-Picard F, Baty D, Berard F, Lacour JP, Passeron T, Chiaverini C. Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment. Br J Dermatol 2018; 180:357-364. [PMID: 29932457 DOI: 10.1111/bjd.16897] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/11/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND Epidermolysis bullosa simplex generalized severe (EBS-gen sev) is a genetic disorder caused by mutation in the KRT5 or KRT14 genes. Although it is usually considered a mechanical disease, recent data argue for additional inflammatory mechanisms. OBJECTIVES To assess the inflammation in the skin of patients with EBS-gen sev. METHODS A first immunohistochemical retrospective study was performed on frozen skin samples from 17 patients with EBS-gen sev. A second multicentre prospective study was conducted on 10 patients with severe EBS-gen sev. Blister fluid and epidermis were processed for immunochemical analysis and quantitative real-time polymerase chain reaction. Cytokine expression was analysed in blister fluid and compared with that in controls. RESULTS Histological analysis showed a constant dermal perivascular CD4+ lymphocyte infiltrate in skin biopsies of both blister (n = 17) and rubbed skin (n = 5), an epidermal infiltration of neutrophils and eosinophils in 70% of cases, and increased immunostaining for CXCL9 and CXCL10 in blistering skin. High levels of T helper 17 cytokines were detected in lesional skin. Three adult patients with EBS-gen sev were treated with apremilast, with a dramatic improvement of skin blistering and good tolerance. CONCLUSIONS Our study demonstrates the importance of inflammation in patients with EBS-gen sev and underlines the key role for T helper 17 cells in its pathogenesis. In addition, this study provides promising new therapeutic approaches for this disabling disorder.
Collapse
|
43
|
Reymann V, Bessis D, Lipsker D, Bergeret B, Du Thanh A, Terrail N, Dandurand M, Dereure O. Efficacité et tolérance du lénalidomide oral à faible dose dans le lupus érythémateux cutané réfractaire : une série ouverte de 19 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
44
|
Pallure V, Boralevi F, Beltran C, Herlin C, Captier G, Bessis D. Alopécie en « auréole » (« halo scalp ring ») : 10 nouveaux cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
45
|
Reymann V, Vincent T, Bessis D, Dereure O, Girard C. Valeur ajoutée des dosages d’infliximab sanguin et d’anticorps anti-infliximab chez les patients psoriasiques. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Best M, Molinari N, Chasset F, Cordel N, Bessis D. Utilité de l’anticorps anti-transcriptional intermediary factor-1gamma (TIF-1γ) dans l’identification du risque de cancer au cours de la dermatomyosite de l’adulte : revue systématique de la littérature et méta-analyse. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
47
|
Cesbron E, Bessis D, Jachiet M, Lipsker D, Cordel N, Bouaziz JD, Bagot M, Arnaud L, Barbaud A, Francès C, Chasset F. Risque de thromboses chez les patients traités par thalidomide pour un lupus érythémateux cutané. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
48
|
Bessis D, Bieth E, Selves J, Girard C, Solassol J, Vendrell J. Hamartome épidermique à type d’acanthosis nigricans : vers une corrélation phénotype–génotype ? Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Alenezi F, Girard C, Guillot B, Bessis D, Du Thanh A, Dereure O. Le méthotrexate est-il vraiment efficace dans les lymphomes cutanés épidermotropes ? Une série rétrospective de 48 patients. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Bessis D, Mestre S, Vabres P, Quéré I, Tosi D. Lymphangiome vulvaire au cours du syndrome de Schimmelpenning–Feuerstein–Mims traité par l’association sirolimus-sunitinib. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|